[Instruction sheet for the treatment of hemorrhagic diathesis].
D000614:Aminocaproates / Q000008:administration & dosage; D000933:Antifibrinolytic Agents / Q000008:administration & dosage*; D007611:Aprotinin / Q000008:administration & dosage; D001779:Blood Coagulation Factors / Q000008:administration & dosage*; D001798:Blood Proteins / Q000008:administration & dosage; D005167:Factor VII / Q000008:administration & dosage; D005169:Factor VIII / Q000008:administration & dosage; D005340:Fibrinogen / Q000008:administration & dosage; D006474:Hemorrhagic Disorders / Q000188:drug therapy*; D006801:Humans; D011479:Protamines / Q000008:administration & dosage; D010837:Vitamin K 1 / Q000008:administration & dosage
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D001779:Blood Coagulation Factors; D001798:Blood Proteins; D011479:Protamines; D010837:Vitamin K 1; D005167:Factor VII; D005169:Factor VIII; D005340:Fibrinogen; D007611:Aprotinin
Merkblatt zur Behandlung derhämorrhagischen Diathesen.